1. Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis. Issue 10 (7th August 2017) Authors: Pennington, Kelly; Sasieta, Humberto C; Ramos, Guiherme P; Erskine, Courtney L; Van Keulen, Virginia P; Peikert, Tobias; Escalante, Patricio Journal: Clinical medicine insights Issue: Issue 10(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial. Issue 1 (4th June 2020) Authors: Zamarin, Dmitriy; Walderich, Sven; Holland, Aliya; Zhou, Qin; Iasonos, Alexia E; Torrisi, Jean M; Merghoub, Taha; Chesebrough, Lewis F; Mcdonnell, Autumn S; Gallagher, Jacqueline M; Li, Yanyun; Hollmann, Travis J; Grisham, Rachel N; Erskine, Courtney L; Block, Mathew S; Knutson, Keith L; O'Cearbh... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗